ADDRESS-2 is now supporting a study to understand better the effect of the drug Abatacept on the immune system in new-onset type 1 diabetes, and how it might work to preserve beta cells.
The Effect of Abatacept on the Immune System in Type 1 Diabetes
This study aims to gain a better understanding of the immune processes that lead to the destruction of insulin producing beta cells. Participants will be given the drug Abatacept for 6 months, in addition to their regular diabetes medication. They will have blood tests before, during and after treatment (6 visits in all) so that we can analyse their immune cells.
We are looking for male and female volunteers aged 18-45 who have been diagnosed with Type 1 Diabetes in the last 100 days.
To find out more contact us
Read about other studies we are supporting.